Sarepta Therapeutics Inc. Supported by Improving Profitability as Shorted Small-Cap Stock

Sarepta Therapeutics Inc. (SRPT) is noted as one of the most shorted small-cap stocks to consider buying, with improving profitability supporting its outlook. This indicates a positive financial trend despite high short interest.